0000876661-22-000049.txt : 20220114
0000876661-22-000049.hdr.sgml : 20220114
20220114090444
ACCESSION NUMBER: 0000876661-22-000049
CONFORMED SUBMISSION TYPE: 25-NSE
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20220114
DATE AS OF CHANGE: 20220114
EFFECTIVENESS DATE: 20220114
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: GELESIS HOLDINGS, INC.
CENTRAL INDEX KEY: 0001805087
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 844730610
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39362
FILM NUMBER: 22530537
BUSINESS ADDRESS:
STREET 1: 501 BOYLSTON STREET, SUITE 6102
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 857-327-7737
MAIL ADDRESS:
STREET 1: 501 BOYLSTON STREET, SUITE 6102
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: CAPSTAR SPECIAL PURPOSE ACQUISITION CORP.
DATE OF NAME CHANGE: 20200227
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: NEW YORK STOCK EXCHANGE LLC
CENTRAL INDEX KEY: 0000876661
IRS NUMBER: 000000000
STATE OF INCORPORATION: NY
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: 11 WALL STREET
CITY: NEW YORK
STATE: NY
ZIP: 10005
BUSINESS PHONE: 212-656-2060
MAIL ADDRESS:
STREET 1: 11 WALL STREET
CITY: NEW YORK
STATE: NY
ZIP: 10005
FORMER COMPANY:
FORMER CONFORMED NAME: NEW YORK STOCK EXCHANGE INC
DATE OF NAME CHANGE: 19910628
25-NSE
1
primary_doc.xml
X0203
0000876661
NEW YORK STOCK EXCHANGE LLC
0001805087
GELESIS HOLDINGS, INC.
001-39362
405 West 14th Street
Austin
TX
TEXAS
78701
(512) 619-2922
Units, each consisting of one share of Class A Common Stock and one-half of one Warrant
17 CFR 240.12d2-2(a)(3)
Christopher Rances
Senior Analyst
2022-01-14
EX-99.25
2
ruleprovisionnotice.htm
NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES
The New York Stock Exchange hereby notifies the SEC of its intention to remove the entire class of the stated securities from listing and registration on the Exchange at the opening of business on January 25, 2022, pursuant to the provisions of Rule 12d2-2 (a).
[ X ] 17 CFR 240.12d2-2(a)(3) That on January 13, 2022 the instruments representing the securities comprising the entire class of this security came to evidence, by operation of law or otherwise, other securities in substitution therefore and represent no other right except, if such be the fact, the right to receive an immediate cash payment.
The merger agreement between Capstar Special Purpose Acquisition Corp. and Gelesis, Inc. became effective on January 13, 2022. The Capstar Special Purpose Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half of one Warrant, automatically separated into the component securities, and, as a result, no longer trade as a separate security.
The Exchange also notifies the Securities and Exchange Commission that as a result of the above indicated conditions this security was suspended from trading on January 14, 2022.